Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- Are synthetic food dyes unsafe? Experts reveal what the research really shows.
- How Much Should Doctors Dwell On Risks?
- NJACTS Community Engagement Core COVID-19 Resources
- Lawsuits Could Choke Off the Candy‑Flavored Vape Pipeline.
- Knowing Your Alzheimer’s Risk May Ease Anxiety but Reduce Motivation for Healthy Habits.
Categories
- Community (2,282)
- Covid (987)
- CTO Events (6)
- News (2,905)
- Pilots (21)